So the company has stated that there is enough cas

So the company has stated that there is enough cash for 2018 studies. Why the 5 million we all ask? Hmmm let's think about this and think about the new financing deal with the 9 month conversion window. The first thing I can think of is the MM study, but that isn't going to take even close to the 5 mil this year. Research is relatively cheap compared to US. The only thing that comes to mind is SALES!. Sales are going to require some major capital. I believe after safety we are going to start selling product in limited countries and expect Israel will be the first, followed by Australia. There are aprox 150,000 psoriasis sufferers in Israel and let's not forget the creme has been tested for other conditions, which we know nothing about yet. We have a monster in the making I believe.